Investigating how thyroid hormone affects cone photoreceptor degeneration in the retina
Thyroid Hormone Signaling and Cone Photoreceptor Degeneration
This study is looking at how thyroid hormones might affect the health of the cells in your eyes that help you see, especially in people with age-related vision problems, to see if lowering these hormones could help protect your eyesight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11087637 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of thyroid hormone (TH) in the degeneration of cone photoreceptors, which are crucial for vision. By using mouse models, the study examines how TH signaling impacts the health of these photoreceptors, particularly in conditions like age-related macular degeneration (AMD). The researchers aim to determine if elevated TH signaling contributes to cone cell death and whether reducing this signaling could protect against vision loss. Patients may benefit from insights that could lead to new treatments for retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with age-related macular degeneration or other retinal diseases that involve cone photoreceptor degeneration.
Not a fit: Patients with retinal conditions unrelated to cone photoreceptor degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to protect vision in patients suffering from retinal degeneration.
How similar studies have performed: Previous research has shown promising results in understanding the role of thyroid hormone in retinal health, suggesting that this approach could yield valuable insights.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Ding, Xi-Qin — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Ding, Xi-Qin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.